Drug Profile
PBI 1402
Alternative Names: PBI-1402Latest Information Update: 14 Oct 2019
Price :
$50
*
At a glance
- Originator ProMetic Life Sciences
- Developer Liminal BioSciences; ProMetic Life Sciences
- Class Chemoprotectants; Colony-stimulating factors
- Mechanism of Action Colony stimulating factor stimulants; Erythropoiesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I/II Anaemia
- No development reported Kidney disorders